Screening for Term Preeclampsia at 35 to 37 Weeks of Gestation: A Single-Center Experience
Fetal Diagnosis and Therapy · 2025
DOI: 10.1159/000547694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2025. Verfasst von Selina Manuela Diethelm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Prevention of preeclampsia has short- and long-term benefits for maternal health. Recent data suggest that combined screening at 35–37 weeks of gestation with anamnestic risk factors, mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), and angiogenic profile (sFlt-1/PlGF) detects up to 80% of all tPE. The aim of this retrospective analysis was to test the performance of third-trimester screening for tPE in a single center in Switzerland.
Methods
Singleton pregnancies with complete background risk assessments, MAP, and, if available, UtA-PI and sFlt-1/PlGF from 2018 to 2023 were included and risks were calculated on the FMF London website.
Results
1,121 pregnancies, including 22 (2.0%) with tPE, were analyzed. Median MAP-MoM [IQR] in tPE was 1.08 [1.00–1.14], compared to 0.98 [0.92–1.04] in controls (p < 0.0001). Median UtA-PI-MoM [IQR] in tPE was 1.04 [0.85–1.27] versus 0.99 [0.82–1.15] (p = 0.56). No sFlt-1/PlGF recordings in tPE were available for analysis. The detection rate in combined screening was 15/22 (68.2%) compared to screening by anamnestic risk factors only of 9/22 (40.9%).
Conclusion
This analysis shows that combined screening at 35–37 weeks of gestation including anamnestic risk factors and MAP performs better than screening by anamnestic risk factors alone. These results should further be verified in a prospective trial including all markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Basel, Basel, Switzerland.
- Department of Obstetrics and Gynaecology, University Hospital of Basel, University of Basel, Basel, Switzerland.
- Department of Obstetrics and Gynaecology, Inselspital Bern, University of Bern, Bern, Switzerland.
- Department of Obstetrics and Gynaecology, University Hospital of Basel, University of Basel, Basel, Switzerland, beatrice.mosimann@usb.ch.
Zitieren
APA
Diethelm, S. M., Musik, T., Monod, C., Hildebrandt, L., Lapaire, O., Manegold-Brauer, G., Amylidi-Mohr, S., & Mosimann, B. (2025). Screening for Term Preeclampsia at 35 to 37 Weeks of Gestation: A Single-Center Experience. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000547694
Vancouver
Diethelm SM, Musik T, Monod C, Hildebrandt L, Lapaire O, Manegold-Brauer G, et al. Screening for Term Preeclampsia at 35 to 37 Weeks of Gestation: A Single-Center Experience. Fetal Diagnosis and Therapy. 2025. doi:10.1159/000547694
BibTeX
@article{Diethelm2025,
author = {Diethelm, Selina Manuela and Musik, Thabea and Monod, Cécile and Hildebrandt, Lysann and Lapaire, Olav and Manegold-Brauer, Gwendolin and Amylidi-Mohr, Sofia and Mosimann, Beatrice},
title = {Screening for Term Preeclampsia at 35 to 37 Weeks of Gestation: A Single-Center Experience},
journal = {Fetal Diagnosis and Therapy},
year = {2025},
doi = {10.1159/000547694}
}
EUVIMED